{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06494397",
            "orgStudyIdInfo": {
                "id": "VP-VHX-896-1103"
            },
            "organization": {
                "fullName": "Vanda Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions",
            "officialTitle": "Crossover Bioequivalence Study of 12 mg VHX-896 and Iloperidone Tablets Under Steady-State Conditions",
            "therapeuticArea": [
                "Mental Health"
            ],
            "study": "pharmacokinetic-study-of-vhx-and-iloperidone-tablets-under-steady-state-conditions"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-07-02",
            "studyFirstSubmitQcDate": "2024-07-02",
            "studyFirstPostDateStruct": {
                "date": "2024-07-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Vanda Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Study to compare the pharmacokinetics and pharmacodynamics of VHX-896 and iloperidone and evaluate the safety and tolerability of VHX-896 and iloperidone in patients with schizophrenia or bipolar I disorder under steady state conditions."
        },
        "conditionsModule": {
            "conditions": [
                "Schizophrenia",
                "Bipolar I Disorder"
            ],
            "keywords": [
                "Iloperidone",
                "VHX-896"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Sequence A: VHX-896 then iloperidone",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: VHX-896 and iloperidone"
                    ]
                },
                {
                    "label": "Sequence B: Iloperidone then VHX-896",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Iloperidone and VHX-896"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "VHX-896 and iloperidone",
                    "description": "oral tablet",
                    "armGroupLabels": [
                        "Sequence A: VHX-896 then iloperidone"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Iloperidone and VHX-896",
                    "description": "oral tablet",
                    "armGroupLabels": [
                        "Sequence B: Iloperidone then VHX-896"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Bioequivalence between VHX-896 tablets relative to iloperidone tablets",
                    "description": "As measured by plasma concentrations",
                    "timeFrame": "12 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Assessment of safety and tolerability of VHX-896 and iloperidone",
                    "description": "As measured by spontaneous reporting of adverse events (AEs).",
                    "timeFrame": "24 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female patients 18 to 65 years of age (inclusive)\n* Diagnosed with either schizophrenia or bipolar I disorder, manic or mixed type, according to the Diagnostic and Statistical Manual of Mental Disorder, Fifth Edition, Text Revision (DSM-5-TR)\n* Patients must be symptomatically stable and on a stable treatment with an oral atypical antipsychotic at an adequate dose (3 months prior to enrollment) and not suffer from acute increase of their psychosis or be hospitalized within the past 2 months\n\nExclusion Criteria:\n\n* History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes\n* Cytochrome P450 2D6 (CYP2D6) poor metabolizers and use of prescription medication or OTC medication that strongly inhibits CYP2D6 or CYP3A4 or induces CYP3A4 within 5 half-lives of baseline",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Vanda Pharmaceuticals Inc.",
                    "role": "CONTACT",
                    "phone": "202-734-3400",
                    "email": "clinicaltrials@vandapharma.com"
                }
            ],
            "locations": [
                {
                    "facility": "Vanda Investigational Site",
                    "city": "Los Alamitos",
                    "state": "California",
                    "zip": "90720",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanda Pharmaceuticals Inc.",
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.80307,
                        "lon": -118.07256
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "city": "Gaithersburg",
                    "state": "Maryland",
                    "zip": "20877",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanda Pharmaceuticals Inc",
                            "role": "CONTACT",
                            "phone": "202-734-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.14344,
                        "lon": -77.20137
                    }
                },
                {
                    "facility": "Vanda Investigational Site",
                    "city": "Marlton",
                    "state": "New Jersey",
                    "zip": "08053",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vanda Pharmaceuticals Inc.",
                            "role": "CONTACT",
                            "phone": "202-733-3400"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.89122,
                        "lon": -74.92183
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012559",
                    "term": "Schizophrenia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019967",
                    "term": "Schizophrenia Spectrum and Other Psychotic Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M15376",
                    "name": "Schizophrenia",
                    "asFound": "Schizophrenia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21838",
                    "name": "Schizophrenia Spectrum and Other Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000081732",
                    "term": "Iloperidone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014150",
                    "term": "Antipsychotic Agents"
                },
                {
                    "id": "D000014149",
                    "term": "Tranquilizing Agents"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M259754",
                    "name": "Iloperidone",
                    "asFound": "Cable",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16904",
                    "name": "Antipsychotic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}